IRVINE, Calif., June 28, 2023 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today presented data on its proprietary Diabetes Bloc-Stim Neuromodulation (DBSN) device in an e-poster at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Meeting,…Read More
ReShape Lifesciences Presents Data on its Proprietary Diabetes BlocStim Neuromodulation Device at the ASMBS 2023 Annual Meeting
